Hydrogen sulfide in gastrointestinal and liver Physiopathology

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 2, 2011, Pages 92-102

  Cipriani, Sabrina ^a   Mencarelli, Andrea ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Colon; Cystathionine synthase (CBS); Cystathionine lyase (CSE); Gut motility and inflammation; Hydrogen sulfide; Liver; Stomach

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE;

COLON; GASTROINTESTINAL TRACT; INTESTINE MOTILITY; INTESTINE MUCOSA; INTESTINE SECRETION; LIVER; LIVER CIRCULATION; PATHOPHYSIOLOGY; REVIEW; STOMACH;

EID: 79952753731     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811794776231     Document Type: Review

References (76)

1. Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev., 2007, 6, 917-935.
2. Martin, G.R.; McKnight, G.W.; Dicay, M.S.; Coffin, C.S.; Ferraz, J.G.; Wallace, J.; Dig, L. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Liver Dis., 2010, 42(2), 103-109.
3. Linden, D.R.; Sha, L.; Mazzone, A.; Stoltz, G.J.; Bernard, C.E.; Furne, J.K.; Levitt, M.D.; Farrugia, G.; Szurszewski, J.H. Production of the gaseous signal molecule hydrogen sulfide in mouse tissues. J. Neurochem., 2008, 106(4),1577-1585.
4. Fiorucci, S.; Distrutti, E.; Cirino, G.; Wallace, J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology, 2006, 131(1), 259-271.
5. Wallace, J.L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci., 2007, 28(10), 501-505.
6. Pitcher, M.C.; Cummings, J.H. Hydrogen sulfide: a bacterial toxin in ulcerative colitis? Gut, 1996, 39(1), 1-4.
7. Jørgensen, J.; Mortensen, P.B. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. Dig. Dis. Sci., 2001, 46(8), 1722-1732.
8. Leschelle, X.; Goubern, M.; Andriamihaja, M.; Blottière, H.M.; Couplan, E.; Gonzalez-Barroso, M.D.; Petit, C.; Pagniez, A.; Chaumontet, C.; Mignotte, B.; Bouillaud, F.; Blachier, F. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim. Biophys. Acta, 2005, 1725(2), 201-212.
9. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; Cirino, G.; Wallace, J.L. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology, 2005, 129(4), 1210-1224.
10. Fiorucci, S.; Santucci, L.; Distrutti, E. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig. Liver Dis., 2007, 39(12), 1043-1051.
11. Fiorucci, S.; Cantucci, L.; Distrutti, E. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig. Liver Dis., 2007, 39(12), 1043-1051.
12. Wallace, J.L.; Dicay, M.; McKnight, W.; Martin, G.R. Hydrogen sulfide enhances ulcer healing in rats. FASEB J., 2007, 21(14), 4070-4076.
13. Wallace, J.L.; Caliendo, G.; Santagada, V.; Cirino, G.; Fiorucci, S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology, 2007, 132(1), 261-271.
14. Tang, G.; Wu, L.; Liang, W.; Wang, R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol. Pharmacol., 2005, 68(6), 1757-1764.
15. Gallego, D.; Clavé, P.; Donovan, J.; Rahmati, R.; Grundy, D.; Jiménez, M.; Beyak, M.J. The gaseous mediator, hydrogen sulfide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum. Neurogastroenterol. Motil., 2008, 20(12), 1306-1316.
16. Teague, B.; Asiedu, S.; Moore, P.K. The smooth muscle relaxant effect of hydrogen sulfide in vitro: evidence for a physiological role to control intestinal contractility. Br. J. Pharmacol., 2002, 137(2), 139-145.
17. Dhaese, I.; Lefebvre, R.A. Myosin light chain phosphatase activation is involved in the hydrogen sulfide-induced relaxation in mouse gastric fundus. Eur. J. Pharmacol., 2009, 606(1-3), 180-186.
18. Dhaese, I.; Van Colen, I.; Lefebvre, R.A. Mechanisms of action of hydrogen sulfide in relaxation of mouse distal colonic smooth muscle. Eur. J. Pharmacol., 2010, 628 (1-3),179-186.
19. Choi, S.; Yeum, C.H.; Chang, I.Y.; You, H.J.; Park, J.S.; Jeong, H.S.; So, I.; Kim, K.W.; Jun, JY. Activating of ATP-dependent K+ channels comprised of Kir6.2 and SUR 2B by PGE2 through EP2 receptor in cultured interstitial cells of Cajal from murine small intestine. Cell Physiol. Biochem., 2006, 18, 187-198.
20. Parajuli, S.P.; Choi, S.; Lee, J.; Kim, Y.D.; Park, C.G.; Kim, M.Y.; Kim, H.I.; Yeum, C.H.; Jun, J.Y. The inhibitory effects of hydrogen sulfide on pacemaker activity of interstitial cells of cajal from mouse small intestine. Korean J. Physiol. Pharmacol., 2010, 14(2), 83-89.
21. Schicho, R.; Krueger, D.; Zeller, F.; Von Weyhern, C.W.; Frieling, T.; Kimura, H.; Ishii, I.; De Giorgio, R.; Campi, B.; Schemann, M. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology, 2006, 131(5), 1542-1552.
22. Schmedes, A.; Nielsen, J.N.; Hey, H.; Brandslund, I. Low Sadenosylmethionine concentrations found in patients with severe inflammatory bowel disease. Clin. Chem. Lab. Med., 2004, 42(6), 648-653.
23. Babidge, W.; Millard, S.; Roediger, W. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol. Cell. Biochem., 1998, 181(1-2), 117-124.
24. Cao, Q.; Zhang, L.; Yang, G.; Xu, C.; Wang, R. Butyratestimulated H2S production in colon cancer cells. Antioxid. Redox. Signal., 2010, 12(9), 1101-1109.
25. Attene-Ramos, M.S.; Wagner, E.D.; Plewa, M.J.; Gaskins, H.R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res., 2006, 4(1), 9-14.
26. Attene-Ramos, M.S.; Nava, G.M.; Muellner, M.G.; Wagner, E.D.; Plewa, M.J.; Gaskins, H.R. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ. Mol. Mutagen., 2010, 51(4), 304-314.
27. Goubern, M.; Andriamihaja, M.; Nübel, T.; Blachier, F.; Bouillaud, F. Sulfide, the first inorganic substrate for human cells. FASEB J., 2007, 21(8), 1699-1706.
28. Wallace, J.L; Vong, L.; McKnight, W.; Dicay, M.; Martin, G.R. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology, 2009, 137(2), 569-578, 578.e1.
29. Fiorucci, S.; Orlandi, S.; Mencarelli, A.; Caliendo, G.; Santagada, V.; Distrutti, E.; Santucci, L.; Cirino, G.; Wallace, J.L. Enhanced activity of a hydrogen sulfide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol., 2007, 150(8), 996-1002.
30. Oh, G.S.; Pae, H.O.; Lee, B.S.; Kim, B.N.; Kim, J.M.; Kim, H.R. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-KB via heme oxygenase-1 expression in AW264.7 macrophages stimulated with lipopolysaccharide. Free Rad. Biol. Med., 2006, 41, 106-119.
31. Zanardo, R.C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J., 2006, 20(12), 2118-2120.
32. Yusof, M.; Kamada, K.; Kalogeris, T.; Gaskin, F.S.; Korthuis, R.J. Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am. J. Physiol. Heart. Circ. Physiol., 2009, 296(3), H868-876.
33. Fiorucci, S.; Antonelli, E.; Mencarelli, A.; Orlandi, S.; Renga, B.; Rizzo, G.; Distrutti, E.; Shah, V.; Morelli, A. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology, 2005, 42(3), 539-548.
34. Fujii, K.; Sakuragawa, T.; Kashiba, M.; Sugiura, Y.; Kondo, M.; Maruyama, K.; Goda, N.; Nimura, Y.; Suematsu, M. Hydrogen sulfide as an endogenous modulator of biliary bicarbonate excretion in the rat liver. Antioxi. Redox Signal, 2005, 7(5-6), 788-794.
35. Greenway, C.V.; Stark, R.D. Hepatic vascular bed. Physiol Rev., 1971, 51, 23-65.
36. Lautt, W.W.; Legare, D.J.; Ezzat, W.R. Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology, 1990, 98, 1024-1028.
37. Richter, S.; Vollmar, B.; Mucke, I.; Post, S.; Menger, M.D. Hepatic arterioloportal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. J. Physiol., 2001, 531, 193-201.
38. Lautt, W.W. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol. Res., 2007, 37, 891-903.
39. Siebert, N.; Cantré, D.; Eipel, C.; Vollmar, B. H2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K(ATP) channels. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 295(6), G1266-1273.
40. Wiest, R.; Groszmann, R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology, 2002, 35, 478-491.
41. Rockey, D.C.; Shah, V. Nitric oxide biology and the liver: report of an AASLD research workshop. Hepatology, 2004, 39, 250-257.
42. Hennenberg, M.; Trebicka, J.; Sauerbruch, T.; Heller, J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut, 2008, 57(9), 1300-1314.
43. Thimgan, M.S.; Yee, H.F. Jr. Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance. Am. J. Physiol., 1999, 277, G137-G143.
44. Refsun, H.; Urland, P.; Nygard, O.; Vollset, S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med., 1998, 49, 31-62.
45. Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.; Graham, I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med., 1991, 324, 1149-1155.
46. McCully, K.S. Homocysteine and vascular disease. Nat. Med., 1996, 2, 386-389.
47. Tawakol, A.; Omland, T.; Gerhard, M.; Wu, J.T.; Creager, M.A. Hyperhomocysteinemia is associated with impaired endotheliumdependent vasodilatation in humans. Circulation, 1997, 95, 1119-1121.
48. Bosy-Westphal, A.; Petersen, S.; Hinrichsen, H.; Czech, N.; Muller, M.J. Increased plasma homocysteine in liver cirrhosis. Hepatol. Res., 2001, 20, 28-38.
49. Kinsell, L.W.; Harper, H.A; Barton, H.C.; Hutchin, M.E.; Hess, J.R. Studies in methionine and sulphur metabolism. I. The fate of intravenously administered methionine in normal individuals and in patients with liver damage. J. Clin. Invest., 1948, 27, 677-688.
50. Distrutti, E.; Mencarelli, A.; Santucci, L.; Renga, B.; Orlandi, S.; Donini, A.; Shah, V.; Fiorucci S. The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology, 2008, 47(2), 659-667.
51. Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M. R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med., 2001, 29, 1303-1310.
52. Casey, L.C.; Balk, R.A.; Bone, R.C. Plasma cytokine and endotoxin level correlate with survival in patients with sepsis syndrome. Ann. Intern. Med., 1999, 119, 771-778.
53. Zhang, H.; Zhi, L.; Moore, P. K.; Bhatia, M. Role of hydrogen sulphide in cecal ligation and puncture-induced sepsis in the mouse. Am. J. Physiol., 2006, 290, L1193-L1201.
54. Zhang, H.; Zhi, L.; Moochhala, S.M.; Moore, P.K.; Bhatia M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture induced sepsis in mice by up-regulating the production of cytokines and chemokines via NF-kB. Am. J. Physiol., 2007, 292, L960-L971.
55. Li, L.; Bhatia M.; Zhu, Y.Z.; Zhu, Y.C.; Ramnath, R.D.; Wang, Z.J.; Anuar, F.B.; Whiteman, M.; Salto-Tellez, M.; Moore, P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharideinduced inflammation in the mouse. FASEB J., 2005, 19, 1196-1198.
56. Collin, M.; Anuar, F.B.; Murch, O.; Bhatia, M.; Moore, P.K.; Thiemermann, C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br. J. Pharmacol., 2005, 146, 498-505.
57. Mok, Y.Y.; Atan, M.S.; Yoke Ping, C.; Zhong Jing, W.; Bhatia, M.; Moochhala S.; Moore P.K. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br. J. Pharmacol., 2004, 143(7), 881-889.
58. Mok, Y.Y.; Moore, P.K. Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm. Res., 2008, 57(11), 512-518.
59. Zhang, H.; Moochhala, S.M.; Bhatia, M. Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J. Immunol., 2008, 181(6), 4320-4331.
60. Li, L.; Salto-Tellez, M.; Tan, C.H.; Whiteman, M.; Moore, P.K. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic. Biol. Med., 2009, 47(1), 103-113.
61. Li, L.; Rossoni, G.; Sparatore, A.; Lee, L. C.; Del Soldato, P.; Moore, P. K. Antiinflammatory and gastrointestinal sparing activity of a novel H2S-releasing diclofenac agent: new insights into the biological roles of H2S. Free Radic. Biol. Med., 2006, 42, 706-719.
62. Kang, K.; Zhao, M.; Jiang, H.; Tan, G.; Pan, S.; Sun X. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl., 2009, 15(10), 1306-1314.
63. Jha, S.; Calvert, J.W.; Duranski, M.R.; Ramachandran, A.; Lefer, D.J. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am. J. Physiol. Heart Circ. Physiol., 2008, 295(2), H801-806.
64. Jaeschke, H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 284, G15-G26.
65. Mato, J.M.; Alvarez, L.; Ortiz, P.; Pajares, M.A. Sadenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther., 1997, 73, 265-280.
66. Kim, S.K.; Seo, J.M.; Jung, Y.S.; Kwak, H.E.; Kim, Y.C. Alterations in hepatic metabolism of sulfur-containing amino acids induced by ethanol in rats. Amino Acids, 2003, 24(1-2), 103-110.
67. Zaragozá, R.; García, C.; Rus, A.D.; Pallardó, F.V.; Barber, T.; Torres, L.; Miralles, V.J.; Viña, J.R. Inhibition of liver transsulphuration pathway by propargylglycine mimics gene expression changes found in the mammary gland of weaned lactating rats: role of glutathione. Biochem. J., 2003, 373 (Pt 3), 825-834.
68. Jacobs, R.L.; Stead, L.M.; Brosnan, M.E.; Brosnan, J.T. Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J. Biol. Chem., 2001, 276 (47), 43740-43747.
69. Jacobs, R.L.; House, J.D.; Brosnan, M.E.; Brosnan, J.T. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes, 1998, 47(12), 1967-1970.
70. Okuno, T.; Ueno, H.; Nakamuro, K. Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver. Biol. Trace Elem. Res., 2006, 109(2), 155-171.
71. Mustafa, A.K.; Gadalla, M.M.; Sen, N.; Kim, S.; Mu, W.; Gazi, S.K.; Barrow, R.K.; Yang, G.; Wang, R.; Snyder, S.H. H2S signals through protein S-sulfhydration. Sci. Signal., 2009, 2(96), ra72.
72. Mustafa, A.K.; Gadalla, M.M.; Snyder, S.H. Signaling by gasotransmitters. Sci. Signal., 2009, 2, re2.
73. Mori, M.; Suematsu, M.; Kyokane, T.; Sano, T.; Suzuki, H.; Yamaguchi, T.; Ishimura Y.; Ishii, H. Carbon monoxide-mediated alterations in paracellular permeability and vesicular transport in acetaminophen-treated perfused rat liver. Hepatology, 1999, 30, 160-168.
74. Kyokane, T.; Norimizu, S.; Taniai, H.; Yamaguchi, T.; Takeoka, S.; Tsuchida, E.; Naito, M.; Nimura, Y.; Ishimura, Y.; Suematsu, M. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology, 2001, 120, 1227-1240.
75. Shintani, T.; Iwabuchi, T.; Soga, T.; Kato, Y.; Yamamoto, T.; Takano, N.; Hishiki T.; Ueno, Y.; Ikeda, S.; Sakuragawa, T.; Ishikawa, K.; Goda, N.; Kitagawa, Y.; Kajimura, M.; Matsumoto, K.; Suematsu, M. Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion. Hepatology, 2009, 49(1), 141-150.
76. Wang, R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J., 2002, 16, 1792-1798.